Bioventus BVS
NASDAQ BVS
$14.31 -0.37 (-2.52%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bioventus (BVS) EPS (Diluted) Growth (3y) (2025 - 2026)

Bioventus (BVS) EPS (Diluted) Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -12.16%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 19.81%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 3.09%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 50.83%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -6.12%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 33.46%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 11.48%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 1,810.75%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 18.07%
10 Bioventus 972.56 Mn 943.11 Mn 105.67 Mn 106.12%

Historic Data

Download Data
DateValue
Mar 28, 2026 26.97%
Dec 31, 2025 38.55%
Sep 27, 2025 27.66%
Jun 28, 2025 216.49%
Mar 29, 2025 -96.53%